AHSP Activators
AHSP Activators are chemical compounds that enhance the functionality of the Alpha Hemoglobin Stabilizing Protein (AHSP), a molecular chaperone that selectively binds to free alpha-hemoglobin (alpha-Hb). The role of AHSP is crucial in red blood cells as it stabilizes alpha-hemoglobin before it forms a complex with beta-hemoglobin to produce functional hemoglobin, which is essential for oxygen transport. Activators of AHSP are thought to increase the efficiency of this stabilization process, ensuring that alpha-hemoglobin maintains its proper conformation and reducing the likelihood of its precipitation, which can lead to ineffective erythropoiesis and various hemoglobinopathies.
The mechanisms of AHSP activation are diverse, reflecting the various stages at which these chemical activators interact with cellular signaling pathways that influence AHSP function. Some activators may bind directly to the AHSP, inducing a conformational change that enhances its affinity for alpha-hemoglobin. Others might interact with the cellular machinery that regulates the synthesis or degradation of AHSP, thereby increasing its bioavailability within the cell. Another subset of AHSP activators may work upstream, modulating the activity of proteins involved in the synthesis of hemoglobin chains, or even further upstream by influencing the transcription factors that control the expression of the AHSP gene itself. Regardless of their point of action, all AHSP activators ultimately converge on the goal of promoting the stabilization of alpha-hemoglobin, ensuring that it can effectively associate with beta-hemoglobin to form the hemoglobin tetramer, which is critical for the red blood cells' ability to transport oxygen efficiently.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which could phosphorylate AHSP or associated regulatory proteins, leading to enhanced AHSP activity in erythropoiesis by stabilizing alpha-hemoglobin. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK which can enhance glucose uptake and fatty acid oxidation. Upon activation, AMPK may indirectly promote AHSP activity by modifying energy metabolism in erythroid precursors, creating an environment conducive to AHSP's role in hemoglobin stabilization. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
Sodium phenylbutyrate acts as a chemical chaperone that may enhance the proper folding and function of proteins. It could indirectly increase AHSP's functional stability and its interaction with alpha-hemoglobin, by improving overall proteostasis in erythroid cells. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $64.00 $176.00 | 7 | |
Cobalt(II) chloride induces hypoxia-like responses including erythropoietin (EPO) production. EPO may increase the demand for AHSP as it promotes erythrocyte production, indirectly enhancing AHSP's functional role in hemoglobin synthesis and stabilization. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, a deacetylase that modulates protein function through deacetylation. Activated SIRT1 may enhance AHSP activity by deacetylating it or its associated binding proteins, potentially increasing its affinity for alpha-hemoglobin and its stability. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a PPARγ agonist, alters lipid metabolism and adipogenesis. Though not directly related to erythropoiesis, PPARγ activation may indirectly affect the red blood cell lineage and thus AHSP activity by modulating the energy balance within the erythroid niche. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Arsenic trioxide can lead to the degradation of promyelocytic leukemia (PML) protein and is involved in cellular differentiation. By promoting erythroid differentiation, it could indirectly increase the functional demands for AHSP in new erythrocytes, enhancing its stability and binding to hemoglobin. | ||||||
Hemin chloride | 16009-13-5 | sc-202646 sc-202646A sc-202646B | 5 g 10 g 25 g | $102.00 $160.00 $326.00 | 9 | |
Hemin, an iron-containing porphyrin, can induce heme oxygenase-1, which may affect iron homeostasis. By altering iron availability, hemin might upregulate the functional role of AHSP in hemoglobin synthesis and encourage its binding activity to free alpha-hemoglobin chains. | ||||||
Manganese(II) sulfate monohydrate | 10034-96-5 | sc-203130 sc-203130A | 100 g 500 g | $41.00 $107.00 | ||
Manganese(II) sulfate is a cofactor for various enzymes and may influence gene expression. It could indirectly heighten AHSP activity by affecting the synthesis of erythropoietic factors or enzymes that modulate hemoglobin's stability and interaction with AHSP. | ||||||
(−)Epicatechin | 490-46-0 | sc-205672 sc-205672A | 1 mg 5 mg | $51.00 $138.00 | ||
Epicatechin activates endothelial nitric oxide synthase, which might enhance erythrocyte production and survival. Enhanced erythropoiesis could raise the need for AHSP's role in stabilizing alpha-hemoglobin, indirectly promoting its activity. | ||||||